Found 2,855 investors
Dansk Erhvervsinvestering
Denmark
Dansk Erhvervsinvestering is a venture capital firm established in 1983 and based in Copenhagen, Denmark. The firm invests in the biotech, medical technology, service, healthcare, industrial and consumer products sectors. It has turned into a "closed-end fund" and no longer seeks any new investments.
Venture Capital
Dan Willstrand
France
Founded in 2018, Techlife Capital is a private equity firm based in Paris, France. The firm seeks to invest in healthcare and technology companies.
Private Equity Firm
DAO Jones
Canada
Mr. Kyle Braatz is a Co-Founder and serves Chief Executive Officer at Fullscript. He is an Angel Investor. He is a Co-Founder and serves as Chief Executive Officer at HealthWave (Healthcare delivery). He also serves as the President and Chief Revenue Officer at Natural Partners Fullscripts. As President, he focuses on growth and commercialization at NPFS. Under Kyle's leadership, Fullscript was named Fastest Growing Company in Ottawa 2 years in a row. Kyle has been awarded Canada's Top 40 under 40, Ottawa's top 40 under 40, and both the Young Achiever Award and the Alterna Social Responsibility Award from the University of Ottawa. He sits on the board of Natural Partners Simple Story Videos and the Ottawa Integrative Cancer Centre.
Individual/Angel
Dara5
United Kingdom
Founded in 2019, Dara5 is a venture capital investment firm based in London, United Kingdom. The firm also employs private equity investments and prefers to make co-investments into series B up to pre-ipo opportunities in the healthcare, SaaS, market places, financial technology, business services, consumer goods, F&B, hospitality, leisure, e-commerce, education, fashion and retail, media and communications sectors.
Venture Capital
Dara Knot Capital Partners
United States
Founded in 2020, Dara Knot Capital Partners is a private investment and advisory firm based in Los Angeles, California. The firm seeks to invest in business services, consumer services and healthcare sectors.
Private Equity Firm
Dave Bagshaw
United States
Mr. Hannes Smarason serves as Senior Advisor at Genuity Science. He co-founded Genuity Science. He is a Board Member of TScan Therapeutics. He is also an angel investor. He co-founded WuXi NextCODE along with Dr. Jeff Gulcher and served as its CEO until March of 2018. He has been a longtime advisor to deCODE genetics and its venture investors Polaris Venture Partners and ARCH Venture Partners and contributed to the strategy that culminated in the $415 million sale of deCODE genetics to Amgen. Mr. Smárason previously served as Chief Financial Officer and Executive Vice President of Business and Finance at the company (1997-2004) during which time deCODE genetics achieved worldwide recognition as the global leader in analyzing and understanding the human genome. During his tenure, Mr. Smárason led the first IPO by an Icelandic company in the U.S., structured and negotiated alliances with pharmaceutical companies and led the strategic acquisition of a drug discovery company. Prior to joining deCODE genetics, he was a consultant at McKinsey & Company serving Fortune 100 clients in the finance, healthcare and hospitality sectors. He also served as the Chairman and CEO of Icelandair and its parent company FL Group in the mid- to late- 2000's. Mr. Smárason has served on boards across a variety of sectors related to investment and advisory activity and is active across a range of charitable organizations. He received his master's degree in management from the Massachusetts Institute of Technology where he also earned his bachelor's degree in mechanical engineering.
Individual/Angel
Dave Stevenson
Philadelphia, Pennsylvania, United States
Dave Stevenson is and investment principle responsible for identifying investment opportunities in emerging healthcare solutions and service...
Investment Partner
David Benshoof Klein
New York, New York, United States
David Benshoof Klein is a healthcare investor and entrepreneur with over 13 years life science industry experience; he has played key roles ...
Individual/Angel
David Carratt
United States
Mr. Peter Frishauf served as Non-Executive Chairman at Crossix Solutions. He was the Advisor at VitaPortal. He served as Advisor at Activate Venture Partners. He is a fixture in New York City's entrepreneurial hi-tech digital health scene, is best known as the founder of Medscape in 1995. He served as an Advisor at Apixio. At the time he served as CEO of SCP Communications, Inc., the Manhattan-based medical information company he started 14 years earlier. Peter was inducted into the Medical Advertising Hall of Fame in 2013, and is listed in Richard Saul Wurman's March, 2002 book, Who's Really Who as one of the 1,000 most creative people in the U.S. He is past president of the Healthcare Marketing & Communications Council, Inc. where members from the pharmaceutical, publishing, medical education and advertising industries worked to improve educational and promotional programs. He is a director of Crossix, Context Matters, and a member of the Advisory Boards of Everyday Health, Activate Venture Partners, TrialX, and the Markle Foundation's Connecting for Health initiative. A frequent speaker and author of hundreds of articles, Peter holds an M.S. in Journalism from Columbia University (1972); and a B.A. from NYU (1970).
Individual/Angel
David Dayan
United States
Founded in 2016, Sage Park is a private equity firm based in Franklin, Tennessee. The firm seeks to invest in companies operating in technology services, hardware, software, business services, logistics, distribution, manufacturing, healthcare sectors.
Private Equity Firm
David Drescher
India
Mr. Swapnil Mehta is an Angel Investor. He serves as Advisor at Abita Healthcare.
Individual/Angel
David Hochman
United States
Mr. Hochman has served as the Chairman of our Board since 2016, and as Chairman of the Board of Motus GI Medical Technologies Ltd., our wholly owned subsidiary, since 2011. Since May 2018, he has been Chairman and Chief Executive Officer of Orchestra BioMed, Inc., a biomedical innovation company focused on bringing high impact procedure based therapeutic innovations to life through risk reward sharing partnerships. From 2006 until 2019, he served as Managing Partner of Orchestra Medical Ventures, LLC, an investment firm that employed a strategy to create, build and invest in medical technology companies intended to generate substantial clinical value. Mr. Hochman has also served as President of Accelerated Technologies, Inc., a medical device accelerator company previously managed by Orchestra Medical Ventures, LLC, and now a wholly owned subsidiary of Orchestra BioMed, Inc. Mr. Hochman has over twenty-four years of medical innovation, entrepreneurial, venture capital and investment banking experience. Mr. Hochman served as a board member of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, from 2013 until 2020. He was a co-founder of Caliber Therapeutics, Inc., a wholly owned subsidiary of Orchestra BioMed, Inc., and was on the Board of Caliber Therapeutics, Inc. from 2009 until 2018. He was a co-founder of BackBeat Medical, Inc., a wholly owned subsidiary of Orchestra BioMed, Inc., and served as its President and a member of its Board since inception in 2010 until 2018. He was a co-founder of FreeHold Surgical, Inc., a wholly owned subsidiary of Orchestra BioMed, Inc., and served as a member of its Board from 2011 until 2018. He also served as a director of Adgero Biopharmaceuticals Holdings, Inc until 2020 when it was acquired by Kintara Therapeutics, Inc. (NASDAQ:KTRA). Prior to joining Orchestra Medical Ventures LLC, Mr. Hochman was Chief Executive Officer of Spencer Trask Edison Partners, LLC, an investment partnership focused on development stage healthcare companies. He was also Managing Director of Spencer Trask Ventures, Inc. during which time he led financing transactions for over twenty early-stage companies. From 1999 to 2006 Mr. Hochman was a board advisor of Health Dialog Services Corporation, a leader in collaborative healthcare management that was acquired in 2008 by the British United Provident Association. From 2005 to 2007, he was a co-founder and board member of PROLOR Biotech, Inc., a biopharmaceutical company developing longer lasting versions of approved therapeutic proteins, which was purchased by Opko Health (NYSE: OPK) in 2013. He is also President and a Board Member of the Mollie Parnis Livingston Foundation, a family foundation. He has a B.A. degree with honors from the University of Michigan. Mr. Hochman was selected as a director due to his history as a director of Motus GI Medical Technologies Ltd., our wholly owned subsidiary, his leadership experience at other public companies, including medical technology companies, his financial experience and his expertise in governance matters.
Individual/Angel
David Lang
Bluffton, South Carolina, United States
David focuses his investments in healthcare, business services and software companies.
Investment Partner
David Suddens
United States
Mr. Aditya Vij is an Angel Investor. He serves as Operating Partner at Kedaara Capital. He serves as Board Member at Sunbeam Auto Private. He has had a career spanning 32 years in the Automotive, Defense and Healthcare sectors and has a proven track record of launching new businesses, successfully managing business turnarounds and growing established operations. He spent twenty-five years in the Automotive Industry, eighteen of which were with General Motors (GM) in key leadership positions in Europe and Asia. Among his significant achievements at GM were the revival of the Saab brand in Sweden, the turnaround and subsequent expansion of GM's businesses in India and attaining market leadership in Central Europe. Most recently, Mr. Vij was the Chief Executive Officer at Fortis Healthcare, one of the largest integrated healthcare delivery service providers in India. Previously, he worked as the Group President - Defense at Punj Lloyd, a leading integrated design, engineering, procurement, construction and project management company. He received an MBA from the International Institute for Management Development (IMD), Switzerland and is a Fellow Chartered Accountant, The Institute of Chartered Accountants of India as well as an alumnus of the Delhi University. He served as Board Member at Air Works India.
Individual/Angel
David Zelman
United States
Ms. Anne DeGheest is a Co-Founder and serves as Managing Director at HealthTech Capital. She serves as an Advisor at Social Starts and is an Angel Investor. Anne DeGheest pioneered the HealthTech or Digital Health space as a healthcare executive, entrepreneur, angel investor, corporate advisor, and mentor capitalist. Anne founded in 2010 HealthTech Capital, a group of private investors and venture capitalists dedicated to funding and mentoring new "HealthTech" startups to decrease healthcare costs and empower patients. She is also the founder of and MedStars, an advisory firm. Her life science portfolio companies have grown into major disruptive companies that have generated over $18 billion in market value. Anne earned a Master in Business Engineering, Brussels, and an MBA, Harvard.
Individual/Angel
Davie Poplar Capital
United States
Davie Poplar Capital is a private equity firm based in Raleigh, North Carolina. The firm seeks to invest in companies operating in healthcare services, education, media, business services, and light manufacturing & distribution sectors.
Private Equity Firm
Dawn Patrol Partners
United States
Dawn Patrol Partners is a private equity firm based in Denver, Colorado. The firm seeks to invest in lower middle-market companies. The firm seeks to invest in lower middle-market healthcare, human capital, and business & industrial services companies operating in sub-industries including education and training, revenue cycle management, staffing, distribution, business process outsourcing, infrastructure services, contract manufacturing, and contract research, multi-site provider groups, SNF clinical services, capital equipment rental, and facilities MRO and waste management, among others.
Growth Capital
Dawson James Securities
Boca Raton, Florida, United States
Dawson James Securities is a full service investment firm specializing in healthcare, biotechnology, technology, and clean-tech sectors.
Biotechnology
CleanTech
Health Care
Venture Capital
Daydreamer Fund
Russian Federation
Founded in 2010, Daydreamer Fund was a venture capital fund that is based in Moscow, Russia. The firm sought to invest in companies operating in the healthcare, fitness and wellness sectors.
Venture Capital
Dayou Century Investment Management
China
Dayou Century Investment Management is a private equity firm founded in 2015 and based in Beijing, China. The firm seeks to make investments in sectors like information technology, TMT, B2C, healthcare, advanced manufacturing, and cleantech.
Growth Capital
Showing 821 to
840 of
2,855 results